Stock
Stock

再生元制药

556.53

Delay
0
Open
557.00
Market Cap
60.31B+
High
563.57
Low
554.80
Close
556.53
Volume
840.56K+
P/E Ratio
0.00
Div/Yield
0.00%
Track The Stock Movement

About 再生元制药

再生元制药公司是一家从事药物发现、发明、开发、生产和商业化的生物技术公司。It产品包括以下品牌:EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, ZALTRAP。公司于1988年1月8日由Alferd G. Gilman、Leonard S. Schleifer和Eric M. Shooter创立,总部位于纽约Tarrytown。

Trade GPT

26/08

特朗普放话对美药价“动真格”,扬言将药价降低1500%

AI Bearish REGN
AI Bearish SRPT
logo

Company

Social

Download

google playapp store

© 2025 Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.

Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.